Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia

NCT01256476 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Dyslipidemia
Mixed Dyslipidemia

Interventions

DRUG: pitavastatin
DRUG: pravastatin

Sponsor

Kowa Research Institute, Inc.